-
The Implications of Recent Data Sets for the Management of Hepatocellular Carcinoma - 7/27/2023
1:02:04
-
Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor - 7/20/2023
1:01:15
-
Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management - 7/18/2023
1:00:50
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers - 7/13/2023
1:03:47
-
Inside the Issue: Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes - 7/11/2023
1:03:15
-
Inside the Issue: Optimizing the Management of Metastatic Urothelial Bladder Cancer - 6/29/2023
1:02:14
-
The Implications of New Research Findings for the Management of Endometrial Cancer - 6/29/2023
1:01:22
-
Oncology Today with Dr Neil Love — HER2-Positive Metastatic Breast Cancer - 5/17/2023
1:02:08
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hepatobiliary Cancers - 5/4/2023
1:03:03
-
Beyond The Guidelines: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Prostate Cancer - 4/30/2023
2:00:37
-
Beyond The Guidelines: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Urothelial Bladder Cancer - 4/30/2023
2:03:45
- Next Page
